FemBioBiz participant: Godfridah Masaiti

Godfridah Masaiti - Student at University of Zambia

Godfridah is conceptualising a transdermal and subdermal patch that will deliver antiretroviral drugs (ARVs) slowly into the body. A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose into a blood stream. The transdermal patch will be short term which will deliver the drug up to 7 days while the sub dermal patch will be able to deliver for a about a month. The patch will ensure that patients will no longer be required to take the drugs on a daily basis.


The value proposition is that it eliminates the cost of the patients having to take the drugs. The ARVs that are currently being prescribed cost $2852 for 30 tablets for the first line. If they have to go the second line, the cost is even higher. The patches she proposes would cost around $8 for transdermal patch and $50 for a sub dermal patch which ensure the cost effective utilisation of the ARVs. The patches will also be convenient for the HIV/AIDS patient, reducing stigma as the patient won’t be seen taking the drugs. This will ultimately improve on adherence and health.